Datameds AI (MEDS) Stock Price, News & Analysis
Company Description
Datameds AI (NASDAQ: MEDS) is classified in the medical distribution industry within the Wholesale-drugs, Proprietaries & Druggists' Sundries sector and carries a market capitalization of $2.9M, ranking #7,121 among all listed U.S. companies by market cap.
MEDS has declined 87.3% over the past year. Shares last traded at $0.9611.
For FY2025, Datameds AI reported revenue of $23.3M with net income of -$101.3M and diluted earnings per share of -$1.43. The company operates at a net profit margin of -433.9%.
This page collects what Stock Titan holds for MEDS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Datameds AI (MEDS) stock last closed at $0.9611. Over the past 12 months, the stock has lost 87.3%. At a market capitalization of $2.9M, MEDS is classified as a micro-cap stock with approximately 3.1M shares outstanding.
MEDS Rankings
Latest News
Datameds AI has 10 recent news articles, with the latest published 7 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include AI, earnings, dividends. View all MEDS news →
SEC Filings
Datameds AI has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form PRE 14C, 1 Form 10-Q, 1 Form NT 10-Q. The most recent filing was submitted on August 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MEDS SEC filings →
Financial Highlights
Datameds AI generated $23.3M in revenue in FY2025, retaining a -27.5% gross margin, operating income reached -$93.7M (-401.7% operating margin), and net income was -$101.3M, reflecting a -433.9% net profit margin. Diluted earnings per share stood at -$1.43. The company generated -$10.9M in operating cash flow. With a current ratio of 0.09, short-term liquidity bears monitoring.
Upcoming Events
Token distribution payment
Galectovid DTC launch
Datameds AI has 2 upcoming scheduled events. The next event, "Token distribution payment", is scheduled for September 9, 2026 (in 5 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the MEDS stock price.
Short Interest History
Short interest in Datameds AI (MEDS) currently stands at 164.8 thousand shares, up 61.6% from the previous reporting period, representing 12.3% of the float. Since July 2026, short interest has increased by 61.6%. This moderate level of short interest indicates notable bearish positioning.
Days to Cover History
Days to cover for Datameds AI (MEDS) currently stands at 1.0 days, down 19.4% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
MEDS Company Profile & Sector Positioning
Datameds AI (MEDS) operates in the Medical Distribution industry within the broader Wholesale-drugs, Proprietaries & Druggists' Sundries sector and is listed on the NASDAQ.